New Version of CRISPR Corrects RNA Defects Linked to Huntington’s, ALS – Technology Networks
Technology Networks |
New Version of CRISPR Corrects RNA Defects Linked to Huntington’s, ALS
Technology Networks Until recently, the CRISPR-Cas9 gene editing technique could only be used to manipulate DNA. In a 2016 study, University of California San Diego School of Medicine researchers repurposed the technique to track RNA in live cells in a method called … Gene editing technique could treat ALS and Huntington’s diseaseEngadget |
|
Pigs could save human lives soon thanks to CRISPR
AGDAILY Using CRISPR genome-editing technology, researchers at Cambridge, Massachusetts-based eGenesis have raised the first litter of piglets, free of PERVs — Active Porcine Endogenous Retrovirus. The fear of transmitting PERVs to humans was one of the … |
|
Does this chip revolutionize gene therapy?
Deutsche Welle Gene-edited embryo study: A ‘milestone’ – or a route toward ‘genetic upgrades’? 02.08.2017. Researchers in the US have used an experimental gene-editing technique to correct a mutation in dozens of embryos. Some hailed the development as illuminating … |
|
Does this chip revolutionize gene therapy?
Deutsche Welle Gene-edited embryo study: A ‘milestone’ – or a route toward ‘genetic upgrades’? 02.08.2017. Researchers in the US have used an experimental gene-editing technique to correct a mutation in dozens of embryos. Some hailed the development as illuminating … |
|
Global Cancer Gene Therapy Market to Grow at a CAGR of 20.6 …
Business Wire (press release) The “Global Cancer Gene Therapy Market 2017-2021” report has been added to Research and Markets’ offering. The global cancer gene therapy ma. |
Proactive Investors UK |
WideCells raises £750000 as it looks to further its penetration of growing stem cell market
Proactive Investors UK Regenerative medicines specialist WideCells Group PLC (LON:WDC) has raised £750,000 through a share placing as it looks to further its penetration of the rapidly growing stem cell market. The London-listed company has issued 5.35mln shares at 14p … WideCells Group PLC Raises £750000 to accelerate the growth of all three divisionsDirectorsTalk Interviews |
Proactive Investors UK |
WideCells raises £750000 as it looks to further its penetration of growing stem cell market
Proactive Investors UK Regenerative medicines specialist WideCells Group PLC (LON:WDC) has raised £750,000 through a share placing as it looks to further its penetration of the rapidly growing stem cell market. The London-listed company has issued 5.35mln shares at 14p … WideCells Group PLC Raises £750000 to accelerate the growth of all three divisionsDirectorsTalk Interviews |
